Novartis AGNVS

Is NVS cheap right now? Every multiple below is scored against its own 10-year range, not a sector average.

$161.10+5.02 (+3.22%)24:00 UTC
NYSEHealthcare

Company snapshot

Market Cap
$307B
Mega-cap
+88%
2016 — today
10-Year Price
+137%
2016 — today
52-Week Range
$122.61$168.62
Current $161.10· 84%

Novartis AG, based in Basel, Switzerland, discovers, develops, and distributes medical products globally through two primary divisions. Innovative Medicines provides prescription drugs across therapeutic areas including ophthalmology, neuroscience, immunology, cardiovascular, and metabolic diseases. Sandoz manufactures and commercializes generic drugs, anti-infectives, biosimilars, and active pharmaceutical ingredients. The firm maintains strategic alliances, including collaborations with Alnylam and Kura Oncology.

Similar companies

Healthcare companies of comparable size to NVS
CompanyP/EDiv yield
AZNAstraZeneca PLC26.21.9%
TMOThermo Fisher Scientific Inc.37.40.3%
MRKMerck & Co., Inc.117.12.3%
UNHUnitedHealth Group Incorporated23.52.2%
AMGNAmgen Inc.28.62.2%
GILDGilead Sciences, Inc.-52.42.0%
ABBVAbbVie Inc.82.02.4%
ABTAbbott Laboratories38.72.4%

Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.

Valuation in context

P/E ratio
30.7
Near historic high
Near historic highs — last 10 years
Sector median 25.2above sector
P/B ratio
8.2
Near historic high
Near historic highs — last 10 years
Sector median 2.2above sector
EV / EBITDA
15.9
Near historic high
Near historic highs — last 10 years
Sector median 15.4in line with sector
Dividend Yield
2.9%
Near historic low
Near historic low — last 10 years
Sector median 1.8%above sector
PEG ratio
7.9
Near historic high
Near historic highs — last 10 years
Sector median 1.8above sector
FCF Yield
4.8%
Near historic low
Near historic low — last 10 years
Sector median -12.6%above sector
Free · No credit card needed

Get alerted when NVS is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.